Healthcare Realty Q4 2024 Earnings Report
Key Takeaways
Healthcare Realty Trust reported a net loss attributable to common stockholders of $(106.8) million, or $(0.31) per diluted common share for the three months ended December 31, 2024. Normalized FFO per share totaled $0.40 for the quarter, up 2.5% over the prior year period. The company closed joint venture and asset sale transactions totaling $522 million and repaid its $350 million term loan maturing in 2025.
Normalized FFO per share totaled $0.40 for the quarter, at the high end of the previously provided guidance range and up 2.5% over the prior year period.
Cash NOI growth in the fourth quarter was 3.1%. Excluding Steward Health and Prospect Medical, cash NOI growth was 3.6%.
The Company closed joint venture and asset sale transactions totaling $522 million in the fourth quarter.
The Company repaid its $350 million term loan maturing in 2025 and ended the year with leverage at 6.4 times net debt to adjusted EBITDA.
Healthcare Realty
Healthcare Realty
Healthcare Realty Revenue by Segment
Forward Guidance
The Company's 2025 same store cash NOI growth estimated guidance range is 3.00% to 3.75%, which excludes the impact of Prospect Medical and Steward Health.